Biotechblog – Page 1044 – Biotechnology business, policy, and more!

An Overview of the Biopharmaceutical Landscape Ahead

John Avellanet, a frequent contributor to this blog, is giving a talk for my biotechnology management class at the NIH […]

The Scientific American WorldView project, where I’ve been serving as lead editorial consultant, is ramping up for its May 20th

Does Roche’s recent acquisition of Genentech mean the end of the big-biotech business model? Has Genentech lost it’s independence? Not

I’ll be giving a talk at the Johns Hopkins Carey Business School Entrepreneurship Conference on March 21st titled “Entrepreneurship: What

The April 2009 issue of the Journal of Commercial Biotechnology is now available. This special issue on education was guest-edited

I am extending my “Best Practices in Biotechnology” book series with additional books in specific niches in biotechnology commercialization. This

I’ll be giving a talk at the Kogod School of Business on Tuesday February 24th on “Drug Development – Balancing

I will be opening the Business Matters for Scientists program at Johns Hopkins Carey School of Business on March 6th

I will be opening the Business Matters for Scientists program at Johns Hopkins Carey School of Business on March 6th

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Solving the FDA Crisis By John Avellanet, Managing